| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Antimicrobial Treatment Options for Difficult-to-Treat Resistant Gram-Negative Bacteria Causing Cystitis, Pyelonephritis, and Prostatitis: A Narrative Review
|
Chou, Andrew
|
|
|
82 |
4 |
p. 407-438
|
artikel
|
| 2 |
Authors’ Reply to Colak et al.: “Managing Diabetic Foot Ulcers: Pharmacotherapy for Wound Healing”
|
Dixon, Danielle
|
|
|
82 |
4 |
p. 487
|
artikel
|
| 3 |
Comment on: “Managing Diabetic Foot Ulcers: Pharmacotherapy for Wound Healing”
|
Colak, Bayram
|
|
|
82 |
4 |
p. 485-486
|
artikel
|
| 4 |
Contemporary Drug Treatment of Advanced Heart Failure with Reduced Ejection Fraction
|
Vishram-Nielsen, Julie K. K.
|
|
|
82 |
4 |
p. 375-405
|
artikel
|
| 5 |
Correction to: Pharmacological Approaches to Managing Violence and Aggression in Prison Populations: Clinical and Ethical Issues
|
Weightman, Michael
|
|
|
82 |
4 |
p. 489
|
artikel
|
| 6 |
Drug Repurposing to Target Neuroinflammation and Sensory Neuron-Dependent Pain
|
Sisignano, Marco
|
|
|
82 |
4 |
p. 357-373
|
artikel
|
| 7 |
First-line Immune Checkpoint Inhibitor Combinations in Metastatic Renal Cell Carcinoma: Where Are We Going, Where Have We Been?
|
Adashek, Jacob J.
|
|
|
82 |
4 |
p. 439-453
|
artikel
|
| 8 |
Molnupiravir: First Approval
|
Syed, Yahiya Y.
|
|
|
82 |
4 |
p. 455-460
|
artikel
|
| 9 |
Olverembatinib: First Approval
|
Dhillon, Sohita
|
|
|
82 |
4 |
p. 469-475
|
artikel
|
| 10 |
Sotrovimab: First Approval
|
Heo, Young-A
|
|
|
82 |
4 |
p. 477-484
|
artikel
|
| 11 |
Tezepelumab: First Approval
|
Hoy, Sheridan M.
|
|
|
82 |
4 |
p. 461-468
|
artikel
|
Tijdschrift beschrijving